JP2021501147A5 - - Google Patents
Info
- Publication number
- JP2021501147A5 JP2021501147A5 JP2020523284A JP2020523284A JP2021501147A5 JP 2021501147 A5 JP2021501147 A5 JP 2021501147A5 JP 2020523284 A JP2020523284 A JP 2020523284A JP 2020523284 A JP2020523284 A JP 2020523284A JP 2021501147 A5 JP2021501147 A5 JP 2021501147A5
- Authority
- JP
- Japan
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023018374A JP7793562B2 (ja) | 2017-10-25 | 2023-02-09 | リン酸化タウペプチドの組成物およびその使用 |
| JP2025113783A JP2025163031A (ja) | 2017-10-25 | 2025-07-04 | リン酸化タウペプチドの組成物およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762577157P | 2017-10-25 | 2017-10-25 | |
| US62/577,157 | 2017-10-25 | ||
| PCT/US2018/057286 WO2019084118A2 (en) | 2017-10-25 | 2018-10-24 | PHOSPHORYLATED TUBE PEPTIDE COMPOSITIONS AND USES THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023018374A Division JP7793562B2 (ja) | 2017-10-25 | 2023-02-09 | リン酸化タウペプチドの組成物およびその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021501147A JP2021501147A (ja) | 2021-01-14 |
| JPWO2019084118A5 JPWO2019084118A5 (https=) | 2024-07-29 |
| JP2021501147A5 true JP2021501147A5 (https=) | 2024-07-29 |
| JP7550643B2 JP7550643B2 (ja) | 2024-09-13 |
Family
ID=64362628
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020523284A Active JP7550643B2 (ja) | 2017-10-25 | 2018-10-24 | リン酸化タウペプチドの組成物およびその使用 |
| JP2023018374A Active JP7793562B2 (ja) | 2017-10-25 | 2023-02-09 | リン酸化タウペプチドの組成物およびその使用 |
| JP2025113783A Pending JP2025163031A (ja) | 2017-10-25 | 2025-07-04 | リン酸化タウペプチドの組成物およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023018374A Active JP7793562B2 (ja) | 2017-10-25 | 2023-02-09 | リン酸化タウペプチドの組成物およびその使用 |
| JP2025113783A Pending JP2025163031A (ja) | 2017-10-25 | 2025-07-04 | リン酸化タウペプチドの組成物およびその使用 |
Country Status (25)
| Country | Link |
|---|---|
| US (4) | US11958889B2 (https=) |
| EP (1) | EP3700556A2 (https=) |
| JP (3) | JP7550643B2 (https=) |
| KR (2) | KR102710762B1 (https=) |
| CN (2) | CN117298259A (https=) |
| AR (1) | AR113792A1 (https=) |
| AU (2) | AU2018355325B2 (https=) |
| BR (1) | BR112020008168A2 (https=) |
| CA (2) | CA3079423A1 (https=) |
| CL (2) | CL2020001070A1 (https=) |
| CO (1) | CO2020006073A2 (https=) |
| CR (1) | CR20240219A (https=) |
| DO (1) | DOP2020000135A (https=) |
| EA (1) | EA202091012A1 (https=) |
| EC (1) | ECSP20026986A (https=) |
| IL (2) | IL273980B2 (https=) |
| JO (1) | JOP20200103A1 (https=) |
| MA (1) | MA50465A (https=) |
| MX (2) | MX2020004338A (https=) |
| MY (1) | MY202233A (https=) |
| PH (1) | PH12020550432A1 (https=) |
| SA (1) | SA520411820B1 (https=) |
| SG (1) | SG11202003556UA (https=) |
| TW (2) | TWI827557B (https=) |
| WO (1) | WO2019084118A2 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102710762B1 (ko) * | 2017-10-25 | 2024-09-25 | 얀센 파마슈티칼즈, 인코포레이티드 | 인산화 타우 펩티드의 조성물 및 이의 용도 |
| WO2020123492A1 (en) * | 2018-12-10 | 2020-06-18 | New York University | Monoclonal antibodies targeting c-terminal region of phosphorylated tau |
| AU2020219804A1 (en) | 2019-02-08 | 2021-08-19 | Ac Immune S.A. | Method of safe administration of phosphorylated Tau peptide vaccine |
| EA202192891A1 (ru) * | 2019-04-24 | 2022-02-04 | Янссен Фармасьютикалз, Инк. | Гетерологичное введение анти-тау вакцин |
| JP7702381B2 (ja) * | 2019-07-08 | 2025-07-03 | アルゼカ バイオサイエンシズ、エルエルシー | タウ病理のためのターゲティングリガンド |
| CA3152239A1 (en) * | 2019-09-23 | 2021-04-01 | Lars Ittner | Treatment of tauopathies |
| WO2021126281A1 (en) | 2019-12-20 | 2021-06-24 | Nammi Therapeutics, Inc. | Formulated and/or co-formulated liposome compositions containing toll-like receptor ("tlr") agonist prodrugs useful in the treatment of cancer and methods thereof |
| US20230131808A1 (en) * | 2020-04-22 | 2023-04-27 | Southlake Pharmaceuticals, Inc. | Pegylated interferon tau and compositions and methods thereof |
| JP7687699B2 (ja) * | 2020-09-08 | 2025-06-03 | 国立大学法人大阪大学 | リン酸化タウタンパク質を標的とする免疫原性組成物 |
| JP2023541671A (ja) * | 2020-09-17 | 2023-10-03 | プロシーナ バイオサイエンシーズ リミテッド | シヌクレイノパチーの処置のためのアルファ－シヌクレインワクチン |
| JP2024532787A (ja) * | 2021-08-12 | 2024-09-10 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | 持続的な免疫応答を誘導するためのリン酸化タウペプチドを含むリポソーム |
| WO2023056369A1 (en) * | 2021-09-29 | 2023-04-06 | Janssen Pharmaceuticals, Inc. | Method of safe administration of tau phosphopeptide conjugate |
| US20250152684A1 (en) * | 2022-02-09 | 2025-05-15 | Ac Immune Sa | Anti-Alpha-Synuclein Therapeutic Vaccines |
| AU2023307073A1 (en) * | 2022-07-14 | 2025-02-27 | Vaxxinity, Inc. | Tau peptide immunogen constructs |
| WO2025090815A1 (en) * | 2023-10-24 | 2025-05-01 | Janssen Pharmaceuticals, Inc. | Method of treating preclinicial alzheimer's disease |
| WO2025109524A1 (en) | 2023-11-22 | 2025-05-30 | Ac Immune Sa | Assays and methods for assessing vaccine preparations |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811310A (en) | 1986-09-30 | 1998-09-22 | Albert Einstein College Of Medicine Of Yeshiva Univ. | The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease |
| HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US7408027B1 (en) | 1991-12-06 | 2008-08-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften | Tools for the diagnosis and treatment of Alzheimer's disease |
| DE69318420T2 (de) | 1992-12-14 | 1999-01-28 | Naamloze Vennootschap Innogenetics S.A., Gent | Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung |
| US7427392B1 (en) | 1994-11-14 | 2008-09-23 | Elan Pharmaceuticals, Inc. | Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau |
| US20020086009A1 (en) | 1996-03-13 | 2002-07-04 | Koichi Ishiguro | Anti-phosphorylated tau protein antibodies and methods for detecting alzheimer`s disease with the use of the same |
| WO1998022120A1 (en) | 1996-11-19 | 1998-05-28 | The Wistar Institute Of Anatomy & Biology | Diagnostic and therapeutic reagents for alzheimer's disease |
| KR20010032753A (ko) | 1997-12-03 | 2001-04-25 | 온토제니, 인코오포레이티드 | 소수적으로 개질된 단백질 조성물 및 방법 |
| US6314469B1 (en) | 1999-02-26 | 2001-11-06 | I-Dns.Net International Pte Ltd | Multi-language domain name service |
| CA2415919A1 (en) | 2000-07-11 | 2002-01-17 | Molecular Geriatrics Corporation | Reagents and methods for identification of binding agents |
| GB0114719D0 (en) | 2001-06-15 | 2001-08-08 | Glaxo Group Ltd | Compound |
| EP1474432A1 (en) | 2002-02-04 | 2004-11-10 | Biomira Inc. | Immunostimulatory, covalently lipidated oligonucleotides |
| JP4662719B2 (ja) | 2002-04-19 | 2011-03-30 | ザ ガバニング カウンシル オブ ザ ユニバーシティ オブ トロント | アルツハイマー病の処置のための免疫学的方法および組成物 |
| EP1585520A1 (en) | 2002-12-24 | 2005-10-19 | Neurochem (International) Limited | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
| EP1691666B1 (en) | 2003-12-12 | 2012-05-30 | University of Washington | Catheterscope 3d guidance and interface system |
| US20050261475A1 (en) | 2004-02-13 | 2005-11-24 | Harvard Medical School | Solid-phase capture-release-tag methods for phosphoproteomic analyses |
| US7238788B2 (en) | 2004-02-18 | 2007-07-03 | University Of Iowa Foundation | Antibodies to phosphorylated tau, methods of making and methods of use |
| NZ562434A (en) | 2005-05-05 | 2010-04-30 | Merck & Co Inc | Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease |
| CA2633399C (en) | 2005-12-12 | 2016-01-26 | Ac Immune S.A. | Therapeutic vaccine |
| WO2007068105A1 (en) | 2005-12-12 | 2007-06-21 | Robarts Research Institute | Method of diagnosing amyotrophic lateral sclerosis |
| JP5823663B2 (ja) | 2006-03-03 | 2015-11-25 | プロミス ニューロサイエンシズ インコーポレイテッド | ミスフォールドｓｏｄ１媒介疾患を処置および検出するための方法および組成物 |
| US8012936B2 (en) | 2006-03-29 | 2011-09-06 | New York University | Tau fragments for immunotherapy |
| WO2008140639A2 (en) | 2007-02-08 | 2008-11-20 | Oligomerix, Inc. | Biomarkers and assays for alzheimer's disease |
| JPWO2009051220A1 (ja) | 2007-10-19 | 2011-03-03 | イムナス・ファーマ株式会社 | Ａβオリゴマーに特異的に結合する抗体およびその利用 |
| US9498522B2 (en) | 2008-08-07 | 2016-11-22 | Mercia Pharma Inc. | Immunotherapeutic compositions for the treatment of alzheimer'S disease |
| CN102365295A (zh) | 2009-01-30 | 2012-02-29 | 阿德利夫股份有限公司 | 构象动力肽 |
| US9605054B2 (en) | 2009-02-23 | 2017-03-28 | The Board Of Trustees Of The University Of Illinois | Composition and method for treating a tauopathy |
| SI2408807T1 (sl) * | 2009-03-18 | 2021-11-30 | Ac Immune Sa | Postopek za terapevtsko uporabo |
| UA107571C2 (xx) | 2009-04-03 | 2015-01-26 | Фармацевтична композиція | |
| CA3239368A1 (en) | 2009-06-10 | 2010-12-16 | New York University | Immunological targeting of pathological tau proteins |
| NZ598356A (en) | 2009-07-30 | 2014-06-27 | Pfizer Vaccines Llc | Antigenic tau peptides and uses thereof |
| WO2011032155A2 (en) | 2009-09-14 | 2011-03-17 | Banyan Biomarkers, Inc. | Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury |
| RU2664452C2 (ru) | 2010-04-19 | 2018-08-17 | Нлифе Терапеутикс, С.Л. | Конъюгат, медицинское средство и способы лечения и/или профилактики депрессии и болезни, связанной с отложением телец Леви |
| EP3527220A1 (en) * | 2010-08-12 | 2019-08-21 | AC Immune S.A. | Vaccine engineering |
| AR083561A1 (es) | 2010-10-26 | 2013-03-06 | Ac Immune Sa | Preparacion de una construccion antigenica |
| GB201112056D0 (en) * | 2011-07-14 | 2011-08-31 | Univ Leuven Kath | Antibodies |
| ES2656442T3 (es) * | 2011-09-19 | 2018-02-27 | Axon Neuroscience Se | Terapia basada en proteínas y diagnóstico de una patología mediada por tau en la enfermedad de Alzheimer |
| US20140314837A1 (en) | 2011-09-23 | 2014-10-23 | Ac Immune S. A. | Vaccine Therapy |
| WO2013058350A1 (ja) | 2011-10-21 | 2013-04-25 | 三菱化学株式会社 | 周期表第１３族金属窒化物半導体結晶の製造方法、及び該製造方法により製造される周期表第１３族金属窒化物半導体結晶 |
| EP2659906A1 (en) | 2012-05-01 | 2013-11-06 | Affiris AG | Compositions |
| US20170368167A9 (en) * | 2012-08-21 | 2017-12-28 | The Institute For Molecular Medicine | Compositions and methods related to neurological disorders |
| US20140056901A1 (en) | 2012-08-21 | 2014-02-27 | The Institute For Molecular Medicine | Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies |
| CA2902026C (en) | 2013-03-13 | 2023-08-29 | Prothena Biosciences Limited | Tau immunotherapy |
| WO2015122922A1 (en) | 2014-02-14 | 2015-08-20 | Ipierian, Inc. | Tau peptides, anti-tau antibodies, and methods of use thereof |
| WO2015197820A1 (en) | 2014-06-26 | 2015-12-30 | Crucell Holland B.V. | Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau |
| EP4465050A3 (en) | 2015-06-05 | 2025-06-11 | Genentech, Inc. | Anti-tau antibodies and methods of use |
| CA2988436A1 (en) | 2015-07-13 | 2017-01-19 | Arvinas, Inc. | Alanine-based modulators of proteolysis and associated methods of use |
| CN108024698B (zh) | 2015-08-14 | 2020-09-15 | 直观外科手术操作公司 | 用于图像引导外科手术的配准系统和方法 |
| CA3022515A1 (en) | 2016-05-02 | 2017-11-09 | Prothena Biosciences Limited | Antibodies recognizing tau |
| MA48595A (fr) | 2016-12-07 | 2020-03-18 | Ac Immune Sa | Anticorps anti-tau et leurs méthodes d'utilisation |
| KR102710762B1 (ko) | 2017-10-25 | 2024-09-25 | 얀센 파마슈티칼즈, 인코포레이티드 | 인산화 타우 펩티드의 조성물 및 이의 용도 |
| EP3706795A4 (en) | 2017-11-09 | 2021-10-13 | Pinteon Therapeutics Inc. | METHODS AND COMPOSITIONS FOR GENERATING AND USING HUMANIZED CONFORMATION SPECIFIC PHOSPHORYLATED TAU ANTIBODIES |
| AU2020219804A1 (en) * | 2019-02-08 | 2021-08-19 | Ac Immune S.A. | Method of safe administration of phosphorylated Tau peptide vaccine |
| EA202192891A1 (ru) | 2019-04-24 | 2022-02-04 | Янссен Фармасьютикалз, Инк. | Гетерологичное введение анти-тау вакцин |
-
2018
- 2018-10-24 KR KR1020207014520A patent/KR102710762B1/ko active Active
- 2018-10-24 JP JP2020523284A patent/JP7550643B2/ja active Active
- 2018-10-24 IL IL273980A patent/IL273980B2/en unknown
- 2018-10-24 US US16/757,621 patent/US11958889B2/en active Active
- 2018-10-24 CR CR20240219A patent/CR20240219A/es unknown
- 2018-10-24 WO PCT/US2018/057286 patent/WO2019084118A2/en not_active Ceased
- 2018-10-24 CN CN202310829637.0A patent/CN117298259A/zh active Pending
- 2018-10-24 TW TW107137586A patent/TWI827557B/zh active
- 2018-10-24 TW TW112117496A patent/TW202333768A/zh unknown
- 2018-10-24 SG SG11202003556UA patent/SG11202003556UA/en unknown
- 2018-10-24 IL IL302108A patent/IL302108A/en unknown
- 2018-10-24 KR KR1020247031724A patent/KR20240145065A/ko active Pending
- 2018-10-24 EA EA202091012A patent/EA202091012A1/ru unknown
- 2018-10-24 MY MYPI2020002058A patent/MY202233A/en unknown
- 2018-10-24 CA CA3079423A patent/CA3079423A1/en active Pending
- 2018-10-24 MA MA050465A patent/MA50465A/fr unknown
- 2018-10-24 US US16/169,215 patent/US11124552B2/en active Active
- 2018-10-24 BR BR112020008168-0A patent/BR112020008168A2/pt unknown
- 2018-10-24 CA CA3279357A patent/CA3279357A1/en active Pending
- 2018-10-24 AR ARP180103100A patent/AR113792A1/es unknown
- 2018-10-24 MX MX2020004338A patent/MX2020004338A/es unknown
- 2018-10-24 CN CN201880083892.2A patent/CN111787942B/zh active Active
- 2018-10-24 JO JOP/2020/0103A patent/JOP20200103A1/ar unknown
- 2018-10-24 EP EP18804745.0A patent/EP3700556A2/en active Pending
- 2018-10-24 AU AU2018355325A patent/AU2018355325B2/en active Active
-
2020
- 2020-04-15 PH PH12020550432A patent/PH12020550432A1/en unknown
- 2020-04-21 CL CL2020001070A patent/CL2020001070A1/es unknown
- 2020-04-23 SA SA520411820A patent/SA520411820B1/ar unknown
- 2020-05-18 CO CONC2020/0006073A patent/CO2020006073A2/es unknown
- 2020-05-22 EC ECSENADI202026986A patent/ECSP20026986A/es unknown
- 2020-07-02 DO DO2020000135A patent/DOP2020000135A/es unknown
- 2020-07-13 MX MX2024012209A patent/MX2024012209A/es unknown
-
2021
- 2021-01-27 CL CL2021000217A patent/CL2021000217A1/es unknown
- 2021-08-19 US US17/445,419 patent/US20210388044A1/en not_active Abandoned
-
2023
- 2023-02-09 JP JP2023018374A patent/JP7793562B2/ja active Active
-
2024
- 2024-11-11 AU AU2024259871A patent/AU2024259871A1/en active Pending
-
2025
- 2025-06-26 US US19/251,637 patent/US20250326806A1/en active Pending
- 2025-07-04 JP JP2025113783A patent/JP2025163031A/ja active Pending